Original whitepaper published December 2018. Now Removed.
Click here for the latest info in this area
The pharmaceutical industry is set to grow at 6.3% per year (CAGR) reaching $1.12tr by 2022. Incremental advancements in R&D productivity has seen a number of treatments moving rapidly through the pipeline, with biologics contributing up to 50% of the Top 100 product sales by 2022.
What's in this report?
This quick-read report picks out key statements and predictions of what drugs and companies
will be dominating the market in 2022. The list is broken down by:
- Product Name
- Generic Name
- Company
- Pharmacological Class
- Historical & Projected Sales
This report also contains key statements and predictions of:
- What company will lead worldwide prescription sales
- What company is expected to record the fastest sales growth (CAGR) by 2022
- What are the most valuable R&D projects
- & more
